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Abstract (250 words) 
Background: Physical inactivity is a highly modifiable risk factor for the development of osteoporosis 
but due to a lack of research that has precisely and objectively meaured physical activity (PA) relevant 
to bone, the specific contribution that PA can make to bone health is poorly understood. This study 
examined whether a more precise measure of PA relelvant to bone was associated with meaures of 
bone health in pre- and post-menopausal women in UK Biobank. Methods: Time spent at intensities 
specific to bone health (≥750 milli-gravitational units [mg] and ≥1000 mg) were analysed from raw tri-
axial acceleration data averaged over 1-second epochs from seven-day monitoring of habitual PA 
using accelerometry-based activity monitors (100 Hz; AX3, Axivity, UK) of 1218 pre- and 1316 post-
menopausal healthy women. In a cross-sectional analysis, associations between categories of time 
(<1, 1-2 and ≥2 minutes) spent above the intensity thresholds and calcaneal quantitative ultrasound 
measures of bone health (bone mineral density T-score, BMDT-score; speed of sound, SOS and 
broadband ultrasound attenuation, BUA) were examined. Results: Compared with <1 minute, 
spending 1-2 or ≥2 minutes/day at intensities ≥1000 mg in pre-menopausal and ≥750 mg in post-
menopausal women was positively associated with BMDT-score, SOS and BUA. Conclusion: Brief 
bursts of high intensity PA relevant to bone health can be captured by applying bone-specific 
thresholds of intensity to raw tri-axial accelerations averaged over 1-second epochs. Accumulating 1-
2 minutes/day of high-intensity PA, equivalent to running in pre-menopausal women and slow jogging 
in post-menopausal women, is associated with better bone health. 
 
KEYWORDS (3-10) 
Osteoporosis, Accelerometer, Raw Acceleration, Quantitative Ultrasound  
 
Medical Subject Headings (MeSH): Osteoporosis, bone, exercise therapy 
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Key Messages (3-5 succinct bullet points) 
Brief bursts of high intensity habitual physical activity beneficial to bone health can be quantified from 
accelerations measured at the wrist with accelerometry-based activity monitors.  
 
This method provides a step-change in the ability to precisely and objectively measure physical activity 
relevant to bone from commercially available tri-axial wrist-worn monitors typically employed in large 
population studies. 
 
Accumulating 1-2 minutes or ≥2 minutes per day of high-intensity physical activity, equivalent to 
running in pre-menopausal women and slow jogging in post-menopausal women, is associated with 
better bone health. 
 
Future research should further exploit high-resolution accelerometry-based activity monitor data to 
determine the optimal temporal characteristics of physical activity for bone health to inform the 
development of manageable and effective physical activity interventions. 
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Introduction 
Osteoporosis is a brittle bone disease that affects women (1 in 3) more than men (1 in 5) especially 
over the age of 50 [1,2]. It causes over 300,000 people a year in the UK [3] and over 2 million in the 
US [4] to suffer a fragility fracture resulting in significant pain, disability, loss of independence and 
increased risk of morbidity especially in the first 6 months after fracture [2,3].  In women the 
incidence of osteoporosis increases dramatically post-menopause [1,2,3] therefore identification of 
strategies that may optimise bone health in both pre and post-menopausal women is a priority. 
 
Physical inactivity is a highly modifiable risk factor for the development of osteoporosis [5,6,7] but 
the specific contribution that physical activity (PA) can make to accruing, maintaining or minimising 
the loss of bone mass is poorly understood compared to other modifiable lifestyle risk factors such 
as diet, smoking and alcohol [2,7,8,9]. While PA guidelines recommending the accumulation of at 
least 150 minutes/week of moderate PA, in bouts of 10 minutes or more, exist for cardivascular and 
metabolic health [10,11], there are no specific PA recommendations for reducing the risk of poor 
bone health which likely benefits from a different dose of activity characterised by short, dynamic, 
sporadic bursts [12,13]. The development of bone-specific PA guidelines is limited by a lack of 
research that has precisely and objectively assessed the influence of exercise interventions [2,14] or 
habitual PA on bone health outcomes. Consequently there is a lack of evidence for positive 
associations between bone mineral density (BMD) and moderate or vigorous intensities of PA in 
women [15,16]. 
 
Until recently, the outcome for objectively measured PA in large cross-sectional bone health studies 
has been time accumulated in sedentary, light, moderate or vigorous intensity categories 
determined from proprietary counts (device specific) from hip-worn monitors summed over user-
defined 15- or 60-second epochs [15,16]. The classification of the intensities corresponds to energy 
expenditure during steady state exercise, making them most relevant to cardiovascular and 
Accepted to IJE April 2017 
 5 
metabolic health [17,18,19]. Chastin and colleagues [16] suggest that their counterintuitive finding 
for the absence of an association between BMD and PA at moderate and vigorous intensities may be 
due to averaging proprietary counts from hip-worn accelerometry-based activity monitors over 60-
second epochs. For short dynamic episodes of activity, averaging has the effect of over-smoothing, 
misclassifying and underestimating time spent in moderate or vigorous intensities, thus failing to 
capture the very activities that are likely to benefit bone [16]. Classification of activity into intensity 
categories calibrated with energy expenditure from steady state activity relevant to cardiovascular 
and metabolic health outcomes may also contribute to the failure to detect an association between 
more dynamic intensities of PA and bone health [20,21,22].  
 
The commercial availability of high-resolution tri-axial accelerometry-based activity monitors that 
collect and store raw acceleration data at up to 100 Hz for seven days provides the opportunity to 
more precisely measure intensities of PA beneficial to bone. We calibrated raw peak acceleration 
from these monitors worn on the hip and wrist with external ground reaction force in adults [21] 
and determined the magnitude of acceleration associated with ground reaction forces that are 
beneficial to bone in pre-menopausal women [23]. Providing a valid measure of activity relevant to 
bone from wrist worn monitors is particularly important because, compared to hip-worn monitors, 
they result in higher levels of participant compliance, greater wear-time and therefore more 
accurate measures of habitual PA [24]. The use of wrist-worn monitors to objectively measure PA is 
becoming more common in large population surveys and national health databases including UK 
Biobank. 
 
UK Biobank is a new open access large-scale prospective epidemiological resource that holds 
baseline measures on 500,000 adults including quantitative ultrasound scanning (QUS) of the heel 
and, in a sub-sample of approximately 100,000 participants, objective measurement of habitual 
(free-living) PA from seven-day monitoring using a commercial wrist-worn tri-axial accelerometer 
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that sampled and stored raw accelerations at 100 Hz. These high-resolution files present a unique 
opportunity to derive a more precise measure of PA relevant to bone from raw acceleration data in a 
large cross-sectional study. Brief bursts of high intensity activity can be quantified using intensity 
thresholds specific to bone health. We hypothesise that precise bone-specific measures of PA will 
predict measures of bone health in both pre- and post-menopausal women independent of PA 
accrued at all other intensities and other factors thought to influence bone.  
 
 
Methods 
Questionnaire and baseline physical measures including QUS of the heel were collected from 
500,000 adults aged 40-69 years attending one of 21 assessment centres across Britain between 
2006 and 2010. Objective measurements of PA were collected in a sub-sample (approximately 
100,000) of the same cohort between 2013 and 2015. Details of recruitment and measurements 
used to obtain data for this resource can be found on the UK Biobank website: 
https://www.ukbiobank.ac.uk. 
 
Study Sample 
To reduce the influence of conditions or treatments affecting either bone health or PA, only ‘healthy’ 
individuals, in the order outlined in Figure 1, were selected. For comparison, where complete sets of 
data were available, general health and activity characteristics for excluded pre- and post-
menopausal samples are presented (Figure 1). Pre-menopausal (n=1218) and post-menopausal 
(n=1316) women forming the included sample were analysed separately due to the potential for 
different PA intensity thresholds to predict bone health in each group.  
 
Figure 1. Here: Study inclusion flow chart 
 
Accepted to IJE April 2017 
 7 
Bone Health Outcome Measures 
Participants had calcaneal QUS measurements of their left and right calcaneus performed using the 
Sahara Clinical Bone Sonometer, (Hologic, Bedford, MA).  BMDT-scores (number of standard 
deviations above or below peak BMD from a young sex-matched average) were derived from 
estimated BMD, calculated using the following formula:  
 
Heel BMD = 0.002592 x (BUA + SOS) – 3.687 g/cm2   Equation 1. 
 
where SOS is the speed of sound (m/s) and BUA is the broadband ultrasound attenuation (dH/MHz) 
[25]. The QUS measurements were averaged between the left and right calcaneus (one 
measurement from each) for each participant. In accordance with good practice, daily quality 
control and cleaning procedures were conducted in line with the manufacturer’s recommendations 
across all assessment centres. Further details of the QUS testing protocol are available on the UK 
Biobank website.  
 
Physical Activity Monitoring 
Raw acceleration files (.cwa) containing seven-day, 100 Hz data from tri-axial AX3 (Axivity, 
Newcastle, UK) accelerometers worn on the dominant wrist were downloaded from UK Biobank and 
auto-calibrated, resampled (100 Hz) and converted to .wav format using open-source software 
(Omgui Version 1.0.0.28; Axivity). An open access package (GGIR Version 1.3-2) in R (http://cran.r-
project.org/) was used to convert raw accelerations (x,y and z axes) in .wav files to magnitudes of 
dynamic acceleration (resultant vector magnitude, corrected for gravity, expressed as Euclidean 
Norm Minus One, ENMO in milli-gravitational units, mg; [26,27]) averaged over 1-second epochs 
from which time accumulated at different intensities from 6 valid days (16 hours/day), including one 
weekend day, of wear was used to calculate an average day of activity. Month of PA measurement 
was extracted to allow for any adjustments in PA due to seasonal variation to be made. 
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Using wrist-worn monitors that produce acceleration magnitudes equivalent to the AX3 [28], 
Hildebrand and colleagues [19] found thresholds of approximately 100 mg and 400 mg represented 
moderate and vigorous intensities of activity based on energy expenditure for 3 and 6 METs, 
respectively, in adults (aged 34 ±10 years). The moderate intensity approximated brisk walking, with 
the vigorous threshold just over half the 750 mg output elicited during running (8 km/h), an activity 
that has been found to exceed impact magnitudes and loading rates beneficial to bone [23,29,30]. 
When calibrating acceleration magnitudes with ground reaction force beneficial to bone [23], the 
thresholds we identified corresponded to the acceleration magnitudes found during running at 8 
km/h (slow jogging) and 10 km/h, equivalent to 750 mg and 1000 mg when averaging over 1-second 
epochs [19,31]. Time spent at intensities ≥750 mg (PA≥750mg) and ≥1000 mg (PA≥1000mg) were 
therefore used in the present study to examine thresholds of activity specific to bone. 
 
Covariates 
Variables collected by UK Biobank that were believed to be, or have previously been shown to be, 
associated with bone health and/or PA were treated as potential covariates. Baseline measures for 
age, height, fat-mass and fat-free mass (bioelectrical impedance; Tanita BC418MA), self-reported 
alcohol, nutritional intake and current medications were extracted from UK Biobank. While 
estimated calcium intake (mg) could intuitively be an important determinant of bone health, it was 
not included as a covariate in this report due to only half the sample providing data for it and the 
absence of any correlation (r=0.001) between calcium intake and BMDT-score in the half that did 
provide a measure. Estimated alcohol consumption (units/week) was calculated from self-reported 
volumes of intake multiplied by units for each alcohol type [32]. Continuous variables for age at 
menarche, the number of years taking contraceptive and years since the menopause (where 
applicable) were extracted or calculated from female-specific factors from the touchscreen 
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questionnaire. The number of years between baseline and PA measures was also calculated to allow 
any influence in time between measures of bone health and PA to be examined. Covariates for PA 
(50-99 mg and 100-749 or 100-999 mg) were created to allow associations between time spent at 
higher intensities and measures of bone health to be analysed independent of time spent being in 
activities at all other intensities. To reduce the amount of dilution that light intensity activity (which 
may also be beneficial to bone; [16]) has on measures of moderate activity and above, time spent in 
50-99 mg was used as a separate PA covariate to time spent between 100-749 mg and 100-999 mg 
for respective analyses. 
 
Statistical Data Analysis  
For the first stage of the model  building process all of the covariates were entered simultaneously  
into the regression model  (Model 1) without removal  (e.g. all entered covariates remained in the 
model irrespective of their p-value). Plotting the residuals of this covariate model against PA≥750mg 
or PA≥1000mg indicated that the relationship was curvilinear requiring a second order polynomial to 
model it. For ease of interpretation we decided to address the curvilinear relationship by converting 
the continuous PA≥750mg/ PA≥1000mg variables into categorical variables (<1, 1-2, ≥2 mins/day). 
The parameters of these categories were chosen after examining the distribution of time spent at 
intensities ≥1000mg and ≥750mg for pre- and post-menopausal women respectively and  
consideration of the lowest accumulated dose of physical activity that would lend itself to a 
plausable public health message. Consequently for  the second stage of the model building process 
(Model 2), we entered the categorical variables for PA≥750mg/ PA≥1000mg (<1 min/day being the 
reference category) into the model that contained all of the covariates with BMDT-score as the 
outcome measure. The models were repeated with BUA and SOS as the outcome measure. A sample 
size of n~1200 and n~1300 in each group provides ~90% power (at p=0.05) to detect very small 
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(~1%, partial R2 change = 0.011) increases in the explained variance of bone health by adding 
PA≥750mg/ PA≥1000mg to a covariate model that already explains ~10% of the variance. All 
analyses were carried out in IBM SPSS Version 23 (IBM, Chicago, IL).   
 
 
Results 
Descriptive statistics for measures of bone health, covariates and PA-by-intensity variables were 
reported in Table 1 for pre-menopausal and post-menopausal women separately.  Means and 
standard deviations are reported for normally distributed variables and medians and interquartile 
ranges for variables that are positively skewed. There was no need to adjust PA data for the 
potential effects of seasonality as there was no evidence in this sample that PA differed by season 
(e.g. summer vs autumn, vs  winter and vs spring  were all p≥0.20 for PA≥1000mg in the pre-
menopausal group and PA≥750mg in the post-menopausal group). Tables 2 and 3 report the beta-
coefficients (with 95% CIs and p-values) for all the PA-by-intensity variables obtained from the full 
model (Model 2) that best predicted bone health measures for pre-menopausal and post-
menopausal women. In addition, the R2 increase for the PA≥750mg or PA≥1000mg variable was 
reported.     
 
Table 1 here: Summary characteristics of pre-menopausal and post-menopausal women. 
 
Pre-menopausal Women    
While there was some evidence that the time spent in PA≥750mg was positively associated with 
BMDT-score (p=0.04), the evidence for PA≥1000mg was much stronger (p=0.001). Additional 
analysis implied that time spent in PA at 750-999 mg (p=0.16) did not contribute at all to the 
association of PA≥750mg, it was due almost completely to time spent at PA≥1000mg. For this 
reason we are not reporting the PA≥750mg variable for pre-menopausal women as this would lead 
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to inappropriate recommendations, we are only reporting the results of the model that examined 
PA≥1000mg. In this final model, PA≥1000mg was the only PA-by-intensity variable that was 
associated with BMD (e.g. BMD was 0.20 [p=0.024] and 0.29 [p<0.001] T-scores higher in pre-
menopausal women who spent 1-2 mins/day and ≥2 mins/day respectively in PA≥1000mg than in 
pre-menopausal women who spent <1 min/day at that intensity, R2 increased by 1.2% [p=0.001] 
from the 1.4% covariate model). There was no evidence that time spent in PA at 50-99 mg or PA at 
100-999 mg were related to BMD with or without PA≥1000mg in the model (with: p=0.943 and 
p=0.987 respectively; without: p=0.674 and p=0.211 respectively). The pattern of results was very 
similar when SOS and BUA were used as the markers of bone health.   
 
Table 2 here: Relationship between physical activity (by intensity) and measures of bone health in 
pre-menopausal women (n=1218). 
 
Post-menopausal Women 
In post-menopausal women the association was much stronger between BMD and PA≥750mg than 
between BMD and PA≥1000mg (unlike in pre-menopausal women). Additional analysis showed that 
the association with PA≥750mg was due almost completely to time spent in PA at 750-999 mg 
(p<0.001), and not at all to time spent in PA≥1000mg (p=0.79). For this reason we are not reporting  
the PA≥1000mg variable for post-menopausal women as this would lead to inappropriate 
recommendations, we are only reporting the results of the model that examined the PA≥750mg 
variable (which clearly includes time in PA≥1000mg). In this final model, PA≥750mg was the only PA-
by-intensity variable that was associated with BMD (e.g. BMD was 0.16 [p=0.024] and 0.27 [p=0.001] 
T-scores higher in post-menopausal women who spent 1-2 mins/day and ≥2 mins/day respectively in 
PA≥750mg than in post-menopausal women who spent <1min/day at that intensity, R2 increased by 
0.9% [p=0.002] from the 7.2% covariate model). There was no evidence that time spent in PA at 50-
99 mg  or PA at 100-749 mg were related to BMD with or without PA≥750mg in the model (with: 
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p=0.823 and p=0.226 respectively; without: p=0.408 and p=0.808 respectively). The pattern of 
results was very similar when SOS and BUA were used as the markers of bone health.   
 
Table 3 here: Relationship between physical activity (by intensity) and measures of bone health in 
post-menopausal women (n=1316). 
 
Discussion 
Using a bone-health specific, precise and objective measure of time spent in high-intensity dynamic 
activity we have demonstrated a step-change in the ability to measure PA relevant to bone and 
revealed a positive association between habitual physical activity and bone health in both pre and 
post-menopausal women. In contrast to previous research, which summed proprietary counts from 
commercially available accelerometers over 15- or 60-second epochs [15,16], the averaging of raw 
accelerations over 1-second epochs ensured that brief bursts of high intensity habitual PA more 
relevant to bone were captured enabling bone-specific intensity thresholds to be applied. With a 
view to developing realistic and achievable bone- and population-specific public health messages, it 
is promising to find that relatively small amounts (1-2 minutes) of habitual PA at ≥1000 mg in pre-
menopausal and ≥750 mg in post-menopausal women are positively associated with measures of 
bone health. High impact activity is generally considered necessary to stimulate bone cells to benefit 
BMD [13] but this osteogenic effect has not always been found in post-menopausal women [29]. 
 
To explain why bone health measures are associated with a different threshold of intensity in pre- 
and post-menopausal women, it is possible as a result of bone strength declining with age, that a 
lower intensity activity in post-menopausal women produces a local bone strain equivalent to a 
higher intensity activity in pre-menopausal women [33]. This is further supported by higher loading 
rates in mature women (55 BW/s, ±9) compared to younger women (37 BW/s, ±8) when running at 
the same speed [34]. Therefore a lower threshold of high intensity activity (750 mg equivalent to a 
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slow jog) in post-menopausal women may provide the same mechanical stimulation as a higher 
threshold of high intensity activity (e.g. 1000 mg equivalent running at 10 km/h) in premenopausal 
women. By extension, it may also be interesting to consider the potential for a lower intensity of 
activity to create sufficient local strain to stimulate bone formation in a less healthy population with 
lower levels of bone health. However, the close proximity of BMDT-Scores of the excluded and 
included participants observed in the current study (-0.21 and -0.11 respectively for pre-menopausal 
women and -0.72 and -0.63 respectively for postmenopausal women) suggest that the activity 
intensities associated with bone health in each excluded menopausal group may not be that 
dissimilar to respective intensities of the included samples. Nonetheless, it would be interesting to 
further explore these intensities in a wider, potentially less healthy population with full 
consideration of a comprehensive list of covariates relevant to the sample. 
 
To our knowledge, no other research producing dynamic measures of acceleration (ENMO) from raw 
accelerations (100 Hz) averaged over 1-second epochs to quantify PA relevant to bone is available 
for comparison. However, methods using a non-commercial uniaxial waist-worn accelerometer with 
an on-board processor to count the number of impact peaks in vertical acceleration during an 
activity intervention, found that positive changes in BMD and calcaneal BUA were evident from 
fewer than 100 daily impacts over 3.9 g (standard acceleration due to gravity), a threshold that is 
indicative of running and jumping [30]. This supports the positive associations found for time spent 
above magnitudes equivalent to running in the present study.  
   
Our results are counter to reports of osteogenic benefits [35] and changes in bone structural 
properties [8] from walking, which yield average (1-second epochs) accelerations of 170 mg during 
steady state activity [19]. A high number (approximately 8500) of peak accelerations at low intensity 
(0.3-1 g represents walking; [30]) have been found to significantly predict changes in bone structure 
e.g. circumference and cortical thickness at the proximal tibia [8]. Given that low-level stimulations 
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normally ‘ignored’ by bone may become highly anabolic if performed at higher frequencies [36,37], 
it may be that osteogenic benefits from lower intensity accelerations averaged over 1-second 
epochs can only be recognised if wider characteristics of PA frequency, bout length and 
intermittence are also described [8,38,39]. Therefore, further research should also consider the 
temporal characteristics of PA such as the distribution of activity bouts and rest periods over 
discrete periods of time [8,13,22,40,41]. 
 
The development of a primary population-based strategy to increase PA at all ages in order to 
prevent osteoporosis and reduce the risk of fragility fractures has been limited by a scarcity of 
research that has accurately determined the influence of exercise intervention type, uptake and 
compliance on bone health outcomes using precise, objective measurements of PA [2,14]. This study 
demonstrates that the method used to analyse raw accelerations from commercially available tri-
axial wrist-worn monitors, typically employed in large population studies, can be used to precisely 
and objectively capture high intensity PA relevant to bone. This could be used to evaluate the 
influence of PA interventions on bone health and to inform the development of manageable PA 
guidelines specific to bone.  
 
A number of limitations of the present study are acknowledged. Averaging accelerations over 1-
second epochs captured high intensity activity relevant to bone more accurately than previous 
studies summing counts over 15- or 60-second epochs; however, it was not possible to count the 
magnitude of individual peaks in raw acceleration using this method. The thresholds used in this 
study however, were specific to the intensities of activity beneficial to bone and are meaningful in 
that they can be described in relation to running speed and duration. In UK Biobank, accelerometer 
data were collected from monitors worn on the dominant wrist, whereas our thresholds and those 
of Hildebrand et al, [19] were developed using the non-dominant wrist. Evidence suggests however, 
that differences in accelerometer output between the dominant and non-dominant wrist are 
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minimal at higher intensities [31]. Therefore, unless an activity that dominates on one side is taking 
place, e.g. racket sports, these high-intensity thresholds are likely appropriate for either wrist. It 
should also be acknowledged that accelerometers only measure acceleration and are not able to 
capture loading, e.g. from resistance type training, which can also benefit bone health. 
 
QUS measurements were used in UK Biobank rather than the current gold standard of DXA for 
measuring bone as it provides a radiation-free and inexpensive method for measuring the density 
and micro-architectural properties of bone. The ultrasound derived modulus of elasticity, as 
measured by the SOS, correlates strongly with values of bone breaking strength derived from static 
loading, while BUA values are reported to be dependent upon trabecular orientation in vitro and to 
be significantly associated with bone structure independently of BMD.  These results can be 
combined to provide a single estimate, which is an analogue of bone mineral density [42].  While 
QUS is not used clinically in the UK, it provides a useful research tool to measure calcaneal estimated 
BMD and is affected by weight-bearing activity; with the calcaneus having a trabecular content 
similar to that of the spine and representing more metabolically active bone, which is likely to 
respond to mechanical and hormonal stimuli more rapidly than cortical bone sites [42]. Finally, as 
this is a cross-sectional study, it may be susceptible to reverse causality whereby time spent being 
physically active at a high intensity could be influenced by bone health.  
 
In conclusion, using precise, objective measures of high-intensity dynamic activity we found that 1-2 
minutes per day of high-intensity dynamic physical activity, equivalent to running in pre-menopausal 
women and slow jogging in post-menopausal women, is associated with better bone health.   
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Table 1.  Summary characteristics of pre-menopausal and post-menopausal women. 
Measures Pre-menopausal 
(n=1218) 
Post-menopausal 
(n=1316) 
Age and time:   
Age at baseline (years)a 46.2 (3.9) 58.9 (5.0) 
Years since menopause (years)* - 7 (3 - 11) 
Age at menarche (years) 13.1 (1.5) 12.9 (1.5) 
Contraceptive pill (years from first to last)* 10 (4 - 18) 6 (0 - 13) 
Years between baseline and PA (years) 4.8 (0.7) 4.8 (0.7) 
Body size and composition:   
Weight (kg)* 65.4 (59.5 - 74.0)  66.4 (60.3 - 74.0) 
Height (m) 1.65 (6.0) 1.63 (6.1) 
Body mass index (BMI, kg/m2)* 24.0 (22.0 - 27.0) 24.9 (22.6 - 27.6) 
Fat mass (kg)* 21.3 (17.1 - 27.4) 23.1 (18.7 - 28.9) 
Fat-free mass (kg)* 44.5 (41.8 - 47.5) 43.3 (40.8 - 46.1) 
Dietary information:   
Consumption of alcohol (units/week)* 6.4 (1.8 - 12.8) 6.4 (1.4 - 11.7) 
Physical activity (by intensity):   
PA=50-99 mg (min/day) 131 (26) 130 (26) 
PA=100-999b/749c mg (min/day) 142 (44) 125 (42) 
PA≥1000 b/750 c mg     (<1 min/day)# 73% (887) 62% (816) 
                                        (1-2 min/day) # 12% (151) 21% (276) 
                                        (≥2 min/day) # 15% (180) 17% (224) 
Bone health:   
Bone mineral density (BMDT-score) -0.11 (0.95) -0.63 (0.96) 
Speed of sound (SOS, m/s) 1563 (28) 1548 (28) 
Broadband ultrasound attenuation (BUA, 
dH/MHz) 
78.4 (14.3) 71.2 (15.1) 
 
 
All values are Means (standard deviations) unless indicated otherwise. * Median (inter quartile 
range).  # Percentage (n). PA = physical activity,  mg = milli-gravitational units, min/day = minutes per 
day 
a – no participant was less than 40y at their baseline measure 
b – threshold for pre-menopausal women 
c – threshold for post-menopausal women 
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Table 2. Relationship between physical activity (by intensity) and measures of bone health in 
pre-menopausal women (n=1218). 
Bone 
Health 
 
Physical activity 
intensity 
Beta 
(unstd) 
95%CI for Beta 
(unstd) 
Beta 
(std) 
p-value 
BMD 
T-score 
PA=50-99 mg 
(per 30 min/day) 
 
0.003 
 
(-0.087 to 0.093) 
 
0.003 
 
0.943 
  
PA=100-999 mg 
(per 30 min/day) 
 
 
-0.0004 
 
 
(-0.060 to 0.060) 
 
 
-0.001 
 
 
0.987 
  
PA≥1000 mg 
    
 (<1 min/day) - - - - 
 (1-2 min/day) 0.196 (0.026 to 0.366) 0.068 0.024 
 (≥2 min/day) 0.291 (0.130 to 0.452) 0.109 <0.001 
  
R2 change for PA≥1000 mg = 0.012 (p=0.001) 
 
SOS 
(m/s) 
PA=50-99 mg 
(per 30 min/day) 
0.390 (-2.000 to 2.770) 0.011 0.754 
  
PA=100-999 mg 
(per 30 min/day) 
 
0.060 
 
(-1.440 to 1.560) 
 
0.003 
 
0.943 
  
PA≥1000 mg 
    
 (<1 min/day) - - - - 
 (1-2 min/day) 6.083 (1.021 to 11.145) 0.071 0.019 
 (≥2 min/day) 9.817 (5.014 to 14.620) 0.123 <0.001 
  
R2 change for PA≥1000 mg = 0.015 (p<0.001) 
 
BUA 
(dH/MHz) 
PA=50-99 mg 
(per 30 min/day) 
-0.240 (-1.455 to 0.975) -0.015 0.683 
  
PA=100-999 mg 
(per 30 min/day) 
 
-0.060 
 
(-0.825 to 0.705) 
 
-0.008 
 
0.849 
  
PA≥1000 mg 
    
 (<1 min/day) - - - - 
 (1-2 min/day) 2.379 (-0.192 to 4.950) 0.055 0.070 
 (≥2 min/day) 2.771 (0.332 to 5.210) 0.069 0.026 
  
R2 change for PA≥1000 mg = 0.005 (p=0.034) 
 
 
PA = physical activity,  mg = milli-gravitational units, min/day = minutes per day, unstd = 
unstandardized, std = standardised, BMD T-score = age adjusted bone mineral density, SOS = 
speed of sound, BUA = broadband ultrasound attenuation. Beta = beta coefficient from multiple 
regression analysis, CI=confidence interval. 
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Table 3. Relationship between physical activity (by intensity) and measures of bone health in 
post-menopausal women (n=1316). 
Bone 
Health 
 
Physical activity 
intensity 
Beta 
(unstd) 
95%CI for Beta 
(unstd) 
Beta 
(std) 
p-value 
BMD 
T-score 
PA=50-99 mg 
(per 30 min/day) 
 
-0.008 
 
(-0.085 to 0.065) 
 
-0.008 
 
0.823 
  
PA=100-749 mg 
(per 30 min/day) 
 
 
-0.032 
 
 
(-0.092 to 0.028) 
 
 
-0.047 
 
 
0.226 
  
PA≥750 mg 
    
 (<1 min/day) - - - - 
 (1-2 min/day) 0.156 (0.021 to 0.292) 0.066 0.024 
 (≥2 min/day) 0.272 (0.114 to 0.431) 0.107 0.001 
  
R2 change for PA≥750 mg = 0.009 (p=0.002)  
 
SOS 
(m/s) 
PA=50-99 mg 
(per 30 min/day) 
 
-0.360 
 
(-2.475 to 1.755) 
 
-0.012 
 
0.731 
  
PA=100-749 mg 
(per 30 min/day) 
 
 
-0.840 
 
 
(-2.340 to 0.660) 
 
 
-0.042 
 
 
0.277 
  
PA≥750 mg 
    
 (<1 min/day) - - - - 
 (1-2 min/day) 4.660 (0.693 to 8.628) 0.068 0.021 
 (≥2 min/day) 8.031 (3.386 to 12.677) 0.108 <0.001 
  
R2 change for PA≥750 mg = 0.009 (p=0.002) 
 
BUA 
(dH/MHz) 
PA=50-99 mg 
(per 30 min/day) 
 
0.016 
 
(-1.109 to 1.141) 
 
0.001 
 
0.977 
  
PA=100-749 mg 
(per 30 min/day) 
 
 
-0.538 
 
 
(-1.348 to 0.272) 
 
 
-0.050 
 
 
0.187 
  
PA≥750 mg 
    
 (<1 min/day) - - - - 
 (1-2 min/day) 2.098 (-0.004 to 4.200) 0.057 0.050 
 (≥2 min/day) 3.734 (1.273 to 6.196) 0.093 0.003 
  
R2 change for PA≥750 mg = 0.007 (p=0.008)  
 
 
PA = physical activity,  mg = milli-gravitational units, min/day = minutes per day, unstd = 
unstandardized, std = standardised, BMD T-score = age adjusted bone mineral density, SOS = 
speed of sound, BUA = broadband ultrasound attenuation. Beta = beta coefficient from multiple 
regression analysis, CI=confidence interval. 
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General health and activity characteristics for excluded pre- and post-menopausal samples 
 Excluded Pre-menopausal (N=2968) Excluded Post-menopausal (N=9421) 
Age (years) 46.4 (4.2) 60.3 (5.1) 
Body mass index (kg/m2) 26.1 (5.1) 26.4 (4.8) 
Overall Health Rating 2 (0.7) 2 (0.7) 
Bone mineral density T-score -0.21 (1.0) -0.72 (1.0) 
Overall acceleration average (mg) 29.6 (10.0) 26.9 (8.1) 
1 Only 12389 of the 34686 cases excluded at Stage 2 have complete data for the characteristics described with largest 
attrition due to incomplete bone densitometry data (16014) 
2 Overall acceleration average in milli-gravitational units (mg) is a measure of general physical activity provided by UK 
Biobank. A higher average mg=a higher level of activity. 
3 Comparison data for the included pre- and post-menopausal samples is presented in Table 1 except for overall health 
ratings (lower number=higher perceived level of health) which are 1.8 (0.6) and 1.8 (0.5) and overall acceleration averages 
which are 32.1 (9.0) and 28.8 (7.5) respectively.  
 
Figure 1. Study inclusion flow chart 
Population Baseline Characteristics 
N=52468 White British females 
Baseline Physical Measure: 
 Left and right bone-densitometry of heel 
N=6062 
Assessment Centre Information: 
Overall Health Rating (Fair-Excellent) 
No long-standing 
illness/disability/infirmity 
No other medical condition 
No history of cancer 
No fractures in the last 5 years 
No fractures resulting from a simple 
fall 
Non-smoker status (current or 
previous) 
N=17782 
Full cases meeting inclusion criteria 
for non-cancer illness, 
treatment/medication codes, 6-day 
accelerometer wear and covariate 
information: 
N=1218 Premenopausal women 
N=1316 Postmenopausal women 
Stage 1: N=51245 excluded 
(In order, N=45415 Males and  
N=5830 non-white British females) 
Stage 2: N=34686 excluded 
(In order, N=1218 poor health status; 
N=90 do not know health status or prefer 
not to answer; *N=14013 long-standing 
illness/disability/infirmity; *N=3447 other 
medical condition (e.g. metabolic, 
neurological, endocrine disorder); 
N=2509 history of cancer; *N=2829 had 
fractures in last 5 years; *N=0 had 
fracture resulting from simple fall; 
N=1570 current smoker; N=8951 
previous smoker; N=59 prefer not to 
answer smoking status) 
Stage 3: N=11720 excluded 
(Incomplete bone-densitometry of heel data) 
Stage 4: N=3528 excluded 
(In order, N=1729 have used HRT; 
N=432 (10% of available sample) raw 
acceleration files failed to process; N=376 
have a non-cancer illness; N=16 on 
medication (e.g. bisphosphonates, 
corticosteroids, immunosuppressants, 
anticoagulants, thyroxine) that could 
influence bone health; N=704 (20% of 
available sample) did not meet 16hr/day, 
6-day wear criteria; N=236 missing other 
covariates; N=35 unconfirmed number of 
years since menopause in 
postmenopausal group) 
UK Biobank 
N=103713 individuals with raw 
acceleration data 
* Including first (2012-2013) or second (2014+)  
  repeat assessments 
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